CLINICAL_TRIALS
trial_result
· 2014-01-09
Clinical Trial Update: Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer [Phase 3]
Summary
A Phase 3 trial evaluating topotecan for relapsed small cell lung cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Case Comprehensive Cancer Center | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED